2021³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Ãá°è½ÉÆ÷Áö¾ö : 2021-04-03±³À°ÀÏÀÚ : 2021-04-03
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ , 4Ãþ ÄÁº¥¼Ç1Ȧ,3Ȧ
±³À°ÁÖÁ¦ :
2021³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Ãá°è½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-704-8574
À̸ÞÀÏ :
app@app2010.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 2 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í * Àü¹®ÀÇ(ȸ¿ø-¿¬È¸ºñ³³ºÎÀÚ) »çÀüµî·Ï50,000/ÇöÀåµî·Ï60,000 * Àü¹®ÀÇ(ȸ¿ø-¿¬È¸ºñ¹Ì³³ÀÚ) »çÀüµî·Ï100,000/ÇöÀåµî·Ï110,000* Àü¹®ÀÇ(ºñȸ¿ø) »çÀüµî·Ï100,000/ÇöÀåµî·Ï110,000 * °£È£»ç(ȸ¿ø-¿¬È¸ºñ³³ºÎÀÚ) »çÀüµî·Ï30,000/ÇöÀåµî·Ï40,000 * °£È£»ç(ȸ¿ø-¿¬È¸ºñ¹Ì³³ÀÚ) »çÀüµî·Ï80,000/ÇöÀåµî·Ï90,000 * °£È£»ç(ºñȸ¿ø) »çÀüµî·Ï80,000/ÇöÀåµî·Ï90,000 * ±ºÀÇ°ü,°øº¸ÀÇ,Àü°øÀÇ,ÀÇ°ú,°£È£´ëÇлý / »çÀüµî·Ï ¹«·á , ÇöÀåµî·Ï 40,000* 65¼¼ ÀÌ»ó ȸ¿ø / »çÀüµî·Ï ¹«·á. ÇöÀåµî·Ï ¹«·á(»çÀüµî·Ï¿¡ ÇÑÇÔ)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 09:00~09:15 CNS & LUTS medication Á¶¼ºÅÂ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 09:15~09:30 Parkinson disease & LUTS ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø)
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 09:30~09:45 Problem-solving on CIC, suprapubic cystostomy, and Foley indwelling ÇÑÁö¿¬(¼º³²½ÃÀÇ·á¿ø)
Åä·Ð 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 09:45~10:00 Panel discussion ()
ÈÞ½Ä 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 10:00~10:20 Coffee Break ()
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 10:20~10:45 Bladder fibrosis as LUTS pathophysiology: prevention & potential treatment ¹èÀçÇö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 10:45~11:00 Urinary microbiome: methodology ±è¾Æ¶÷(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 11:00~11:15 Urinary microbiome: report & interpretation À±Çϳª(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 11:15~11:30 Urinary microbiome in OAB, IC (BPS) Á¶°ÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 11:30~11:45 Urinary microbiome in BPH, CPPS Ã߹μö(¼¿ïÀÇ´ë)
Åä·Ð 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 11:45~12:00 Panel discussion ()
±âŸ 04-03 ÄÁº¥¼ÇȦ 4Ãþ 1Ȧ 12:00~12:00 Closing ()